Assisted fundraising

Log in  |  Sign up

  • Home
  • Guides
  • Assets
  • Investors
    • VC funds
    • Tailored lists
    • Favorites
  • Academy
  • Privacy policy
    • Terms of Use
    • Privacy Policy
  • Help center
  • Return to waveup.com

Fund profile

Forbion

Forbion

Netherlands

Leading

About

Forbion, a venture capital firm based in the Netherlands, specializes in investing in life sciences companies. Founded in 2006, Forbion focuses on drug development, medical devices, and diagnostics, addressing high medical needs. The firm has raised significant funds, including €190 million for its FCF I Co-Invest Fund and FCF II, targeting private companies primarily in Europe, with additional investments in North America and Israel. Forbion's notable portfolio companies include Replimune, a leader in oncolytic immunotherapies, and Gyroscope Therapeutics, which was acquired by Novartis. The firm has a strong track record with successful exits, such as the sale of Fovea Pharmaceuticals to Sanofi-Aventis and the acquisition of PanGenetics by Abbott. The firm is led by Managing Partner Bart Bergstein and has expanded its European presence with offices in Naarden and Munich. Forbion's investment strategy focuses on creating value through active involvement and leading investment syndicates in the life sciences sector.

Details

Round

Seed
Series A
Series B
Series C+
Post-IPO Equity

Previous Investments

Biotech
Food & Beverage
Hardware. Robotics & IoT
Healthtech & Wellness
Other
Pharma
Software & Apps

Geo focus

Europe

Highlights

$10.1M

Historical average check

$555M

Historical max check

January 2025

Last investment date

155

Investments

Biotech

Pharma

Healthtech & Wellness

Data & Analytics

Food & Beverage

Other

Showing 0 lists

Filter by

Sort by

Contacts

Website

forbion.com

Email

info@forbion.com

Social

Lists that include this fund